World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
60706
World Ranking
5894
National Ranking
74

Overview

Jean Bourhis is affiliated with the University of Lausanne in Switzerland and has a significant research footprint in the field of Medicine, with a focus on pulmonary and respiratory medicine, oncology, otorhinolaryngology, radiation, and radiology, nuclear medicine and imaging. Their scholarly output includes 437 publications within Medicine, with notable contributions to subfields such as pulmonary and respiratory medicine (112 publications), oncology (64 publications), otorhinolaryngology (63 publications), radiation (62 publications), and radiology, nuclear medicine and imaging (47 publications).

The scientist's research covers several key topics, including head and neck cancer studies, advanced radiotherapy techniques, radiation therapy and dosimetry, lung cancer treatments and mutations, hematopoietic stem cell transplantation, lung cancer diagnosis and treatment, and cancer immunotherapy and biomarkers. The prominence of head and neck cancer studies (124 publications) and advanced radiotherapy techniques (104 publications) highlights a specialized expertise in these areas.

Jean Bourhis has frequently published in several academic journals, with the highest number of publications appearing in Radiotherapy and Oncology (29), followed by Annals of Oncology (14), Blood (14), Medical Physics (10), and the International Journal of Radiation Oncology*Biology*Physics (9).

The scientist has collaborated with a variety of coauthors, including Raphaël Moeckli (54 joint publications), François Bochud (40), Juliette Thariat (28), Y. Pointreau (25), and Claude Bailat (22), illustrating a network of frequent research partnerships.

Selected recent papers authored or coauthored by Jean Bourhis include:

  • Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial, 2021, The Lancet Oncology
  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group, 2021, Radiotherapy and Oncology
  • Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice, 2020, Clinical Cancer Research
  • Towards clinical translation of FLASH radiotherapy, 2022, Nature Reviews Clinical Oncology
  • Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial, 2021, The Lancet Oncology

Best Publications

  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

    Jean-Pierre Pignon;Aurélie le Maître;Emilie Maillard;Jean Bourhis

  • Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid

  • Postoperative Irradiation With or Without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

    Jacques Bernier;Christian Domenge;Mahmut Ozsahin;Katarzyna Matuszewska

  • Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

    Jacques Bernier;Jay S. Cooper;T. F. Pajak;M. Van Glabbeke

  • Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

    Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang

  • Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice

    Vincent Favaudon;Vincent Favaudon;Laura Caplier;Virginie Monceau;Virginie Monceau;Frédéric Pouzoulet;Frédéric Pouzoulet

  • Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients

    Bertrand Baujat;Hélène Audry;Jean Bourhis;Anthony Tak-cheung Chan

  • Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02

    Lester J. Peters;Brian O'Sullivan;Jordi Giralt;Thomas J. Fitzgerald

  • Treatment of a first patient with FLASH-radiotherapy.

    Jean Bourhis;Wendy Jeanneret Sozzi;Patrik Gonçalves Jorge;Olivier Gaide

  • Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

    Pierre Blanchard;Pierre Blanchard;Anne Lee;Sophie Marguet;Julie Leclercq

  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site

    Pierre Blanchard;Bertrand Baujat;Victoria Holostenco;Abderrahmane Bourredjem

  • Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

    José Baselga;José M. Trigo;Jean Bourhis;Jacques Tortochaux

  • The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.

    Marie Catherine Vozenin;Pauline De Fornel;Kristoffer Petersson;Vincent Favaudon

  • CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.

    Charlotte L. Brouwer;Roel J.H.M. Steenbakkers;Jean Bourhis;Wilfried Budach

  • Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle

    Didier Blaise;Mathieu Kuentz;Cecile Fortanier;Jean Henri Bourhis

  • Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer

    Markhaba Tukenova;Catherine Guibout;Odile Oberlin;Françoise Doyon

  • Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s

    Pierre Montay-Gruel;Pierre Montay-Gruel;Kristoffer Petersson;Maud Jaccard;Gaël Boivin

  • Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma.

    Frederic Garban;Michel Attal;Mauricette Michallet;Cyrille Hulin

  • Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

    Stefan Suciu;Franco Mandelli;Theo de Witte;Robert Zittoun

  • Radiotherapy combination opportunities leveraging immunity for the next oncology practice.

    Fernanda G. Herrera;Jean Bourhis;George Coukos;George Coukos

Frequent Co-Authors

Gérard Socié
Gérard Socié Université Paris Cité
Arnon Nagler
Arnon Nagler Sheba Medical Center
Myriam Labopin
Myriam Labopin Université Paris Cité
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Guido Kroemer
Guido Kroemer Université Paris Cité
Vincent Grégoire
Vincent Grégoire Université Catholique de Louvain
Brian O'Sullivan
Brian O'Sullivan Princess Margaret Cancer Centre
Salem Chouaib
Salem Chouaib Gulf Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in medicine or healthcare, online degrees provide flexible options to advance your education and open new professional pathways. Many students begin with nursing, and exploring the easiest rn program can be a helpful way to enter the medical field quickly and gain valuable clinical experience.

If you are already a registered nurse, earning a BSN is a popular next step. Understanding the average cost of rn to bsn programs can help you make budget-friendly decisions while upgrading your credentials. For non-nurses with a bachelor’s degree in another field, an online direct entry msn offers a streamlined route into advanced nursing roles.

Ambitious healthcare professionals can further their expertise with a phd in nursing. This advanced degree opens doors in research, leadership, and academia, making a lasting impact on the field. Explore these online options to align your education with your medical career goals.

Best Scientists Citing Jean Bourhis

Trending Scientists